U.S. federal trademark · Serial No. 97127433
The goods associated with our mark will be for internal and external wound care. We will use our direct internal delivery system of cannabinoids to be applied to the site of injury for open head neurotrauma wounds via our infused absorbable bandage. We will use direct internal delivery of cannabinoids to the site of injury for open spinal cord neurotrauma wounds via our infused absorbable bandage. We will use indirect delivery of cannabinoids to the brain for closed head neurotrauma wounds via nanoparticle delivery system; or by indirect delivery of cannabinoids to the brain for closed spinal cord neurotrauma wounds via nanoparticle delivery system; or by direct internal and external delivery systems of cannabinoids to dermal wounds for faster healing of subdermal and dermal skin layers
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.